BR0313220A - Pelìcula de revestimento para comprimidos e cápsulas - Google Patents

Pelìcula de revestimento para comprimidos e cápsulas

Info

Publication number
BR0313220A
BR0313220A BR0313220-0A BR0313220A BR0313220A BR 0313220 A BR0313220 A BR 0313220A BR 0313220 A BR0313220 A BR 0313220A BR 0313220 A BR0313220 A BR 0313220A
Authority
BR
Brazil
Prior art keywords
tablets
capsules
coating film
dosage forms
coating compositions
Prior art date
Application number
BR0313220-0A
Other languages
English (en)
Inventor
Dominique Nicolas Cade
Ewart Thomas Cole
Frederic Jean Joseph Hoehn
Robert Anthony Scott
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0313220A publication Critical patent/BR0313220A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Wrappers (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

"PELìCULA DE REVESTIMENTO PARA COMPRIMIDOS E CáPSULAS". A presente invenção refere-se a novas composições de revestimento para aplicação a formas sólidas de doseamento como comprimidos ou cápsulas, formas sólidas de doseamento revestidas com a composição e métodos de preparar as referidas composições de revestimento.
BR0313220-0A 2002-08-09 2003-07-30 Pelìcula de revestimento para comprimidos e cápsulas BR0313220A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02292020A EP1396263A1 (en) 2002-08-09 2002-08-09 Film coating for tablets and caplets
PCT/IB2003/003442 WO2004014344A1 (en) 2002-08-09 2003-07-30 Film coating for tablets and caplets

Publications (1)

Publication Number Publication Date
BR0313220A true BR0313220A (pt) 2005-06-14

Family

ID=31502831

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313220-0A BR0313220A (pt) 2002-08-09 2003-07-30 Pelìcula de revestimento para comprimidos e cápsulas

Country Status (16)

Country Link
US (3) US7914820B2 (pt)
EP (2) EP1396263A1 (pt)
JP (2) JP4652052B2 (pt)
CN (1) CN100500137C (pt)
AT (1) ATE497760T1 (pt)
AU (1) AU2003249464C1 (pt)
BR (1) BR0313220A (pt)
CA (1) CA2494045C (pt)
DE (1) DE60335991D1 (pt)
EA (1) EA007619B1 (pt)
ES (1) ES2357949T3 (pt)
MX (1) MXPA05001605A (pt)
NZ (1) NZ537750A (pt)
PT (1) PT1539114E (pt)
SI (1) SI1539114T1 (pt)
WO (1) WO2004014344A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
ES2390293T3 (es) 2006-09-15 2012-11-08 Capsugel Belgium Nv Forma de dosificación de disgregación rápida
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
KR20140076621A (ko) * 2011-10-12 2014-06-20 다우 글로벌 테크놀로지스 엘엘씨 사출 성형된 투여형
WO2015187736A1 (en) * 2014-06-02 2015-12-10 Allergen Research Corporation Placebo formulations and uses thereof
US9744221B2 (en) 2014-12-23 2017-08-29 Synthetic Biologics, Inc. Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
WO2019032573A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER
CA3087569A1 (en) 2018-01-09 2019-07-18 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
EP4275761A3 (en) 2018-03-20 2024-02-28 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
CN109535496A (zh) * 2018-11-13 2019-03-29 黄冈师范学院 一种可降解的透水性包衣膜的制备方法
JP2022547330A (ja) 2019-09-13 2022-11-11 フィンチ セラピューティクス ホールディングス エルエルシー 自閉症スペクトラム障害を治療するための組成物および方法
US20240131082A1 (en) 2019-10-18 2024-04-25 Finch Therapeutics Holdings Llc Compositions and Methods for Delivering a Bacterial Metabolite to a Subject
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021142353A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatitis b (hbv) and hepatitis d (hdv)
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
WO2021202806A1 (en) 2020-03-31 2021-10-07 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
WO2022178294A1 (en) 2021-02-19 2022-08-25 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA753851B (en) * 1974-08-01 1976-05-26 Ici Ltd Film coating process
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
GB2256648B (en) * 1991-05-29 1995-08-30 Colorcon Ltd Wax polish composition
JPH05144624A (ja) 1991-11-21 1993-06-11 Mitsubishi Steel Mfg Co Ltd 磁気記録媒体およびその製造方法
JP3703481B2 (ja) * 1992-01-17 2005-10-05 バーウィンド・ファーマスーティカル・サーヴィスィーズ・インコーポレーテッド セルロース重合体およびラクトースに基づくフィルム被覆および被覆組成物
TW237386B (pt) * 1992-04-15 1995-01-01 Ciba Geigy
JPH06157325A (ja) * 1992-11-30 1994-06-03 Mitsubishi Kasei Corp 経口コレステロール低下剤
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
DE69518006T2 (de) * 1994-12-16 2000-12-21 Warner Lambert Co Verfahren zur einkapselung von tabletten in eine kapsel und feststoff-dosierungsformen erhaltbar durch dieses verfahren
US6245350B1 (en) 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
RU2193880C2 (ru) * 1997-06-11 2002-12-10 Дзе Проктер Энд Гэмбл Компани Покрытая пленкой таблетка улучшенной безопасности для верхних отделов желудочно-кишечного тракта
JP3677156B2 (ja) * 1997-09-05 2005-07-27 武田薬品工業株式会社 医薬
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
DE10033023A1 (de) * 2000-07-07 2002-01-31 Biogrund Gmbh Filmüberzugszusammensetzung auf Basis von Zellulosederivaten und Zuckeralkoholen
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
JP3885484B2 (ja) * 2000-11-07 2007-02-21 カシオ計算機株式会社 データ通信処理装置及び記録媒体
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
JP5144624B2 (ja) 2009-10-28 2013-02-13 京セラドキュメントソリューションズ株式会社 画像形成装置

Also Published As

Publication number Publication date
US20050249810A1 (en) 2005-11-10
ATE497760T1 (de) 2011-02-15
EA200500074A1 (ru) 2005-08-25
ES2357949T3 (es) 2011-05-04
CA2494045C (en) 2010-01-05
AU2003249464B2 (en) 2008-09-25
WO2004014344A1 (en) 2004-02-19
MXPA05001605A (es) 2005-04-25
EP1396263A1 (en) 2004-03-10
CN100500137C (zh) 2009-06-17
EP1539114A1 (en) 2005-06-15
JP2005539019A (ja) 2005-12-22
AU2003249464A1 (en) 2004-02-25
JP4652052B2 (ja) 2011-03-16
EA007619B1 (ru) 2006-12-29
JP2011026337A (ja) 2011-02-10
CN1674876A (zh) 2005-09-28
US7914820B2 (en) 2011-03-29
US20140105975A1 (en) 2014-04-17
PT1539114E (pt) 2011-03-24
AU2003249464C1 (en) 2009-03-05
US8557294B2 (en) 2013-10-15
EP1539114B1 (en) 2011-02-09
NZ537750A (en) 2007-09-28
DE60335991D1 (de) 2011-03-24
CA2494045A1 (en) 2004-02-19
US20110142925A1 (en) 2011-06-16
SI1539114T1 (sl) 2011-05-31

Similar Documents

Publication Publication Date Title
BR0313220A (pt) Pelìcula de revestimento para comprimidos e cápsulas
UA86413C2 (ru) Сахарное покрытие и твердая дозированая форма, которая его содержит
NO20062824L (no) 1,3-Difenylprop-2-en-1-on-avledete forbindelser, fremgangsmater for fremstilling derav, samt anvendelse av samme
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
SE0101675D0 (sv) Novel composition
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
TW200612892A (en) Novel compounds
CL2007002867A1 (es) Compuestos derivados de 2-(bencimidazolil)purina, inhibidores de janus quinasa 3; composicion farmaceutica que los contiene; y su uso para tratar enfermedades autoinmune, inflamatorias, cardiovasculares, rechazo de implante, entre otras.
CL2004001069A1 (es) Compuestos derivados de 1-benzoil-isoquinolinas sustituidos; procedimiento de preparacion, composicion farmaceutica; y uso para el tratamiento o profilaxis de diabetes tipo ii.
TW200740799A (en) Alpha2C adrenoreceptor agonists
BR0307833A (pt) Sìntese controlada de ziprasidona e suas composições
BRPI0512820A (pt) composição de matéria, e método de revestir um metal
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
SE0301700D0 (sv) Novel compounds
CL2007003423A1 (es) Compuestos derivados de pirimidinas sustituidas; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de artritis reumatoidea, aterosclerosis, entre otras enfermeda
EA200600320A1 (ru) γ-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
EA200600321A1 (ru) βd-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
CL2007003265A1 (es) Compuestos derivados de 1h-piran[2,3-d]pirimidin-2,4,7-triona; y composicion farmaceutica, util para el tratamiento de sindrome metabolico, dislipidemia y enfermedades cardiovasculares entre otras.
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
JO2578B1 (en) Compounds Theophene benzimidazole
NO20054787D0 (no) Indenderivater som farmasotiske midler
ES2340502T3 (es) Compuestos de 1,4,8-triazaespiro(4,5)decan-2-ona sustituidos para el tratamiento de la obesidad.
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2317 DE 02-06-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.